ShareOnepro 40 tablet: Each delayed release tablet contains Esomeprazole Magnesium Trihydrate BP equivalent to Esomeprazole 40 mg.
• Treatment of Gastroesophageal Reflux Disease (GERD) -Healing of Erosive Esophagitis -Maintenance of Healing of Erosive Esophagitis -Symptomatic Gastroesophageal Reflux Disease • H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence • Zollinger-Ellison Syndrome • Acid Related Dyspepsia • Duodenal and Gastric Ulcer
Onepro delayed release tablet/capsule should be swallowed whole and taken at least one hour before eating. The majority of patients are healed within 4 to 8 weeks. For patients who do not heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
In general, Esomeprazole was well tolerated in both short- and long-term clinical trials. The most frequently occurring adverse events (≥1%) are headache and diarrhea. Nausea, flatulence, abdominal pain, constipation and dry mouth occurred at similar rates among patients taking Esomeprazole.
In Pregnancy: Pregnancy Category B. This drug should be used during pregnancy only if clearly needed. In Lactation: The excretion of Esomeprazole in milk has not been studied. As Esomeprazole is likely to be excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
| Medicine Formation | Tablet |
|---|---|
| Manufactured By | One Pharma |
Write Your Own Review